IFNA1 and hepatocellular carcinoma: Since there was a large difference in the SVR rate between the IFN group and the IFN-free DAA group, factors associated with early recurrence within 24 weeks of completing antiviral therapy after HCC curative therapy were analyzed within the subgroup of patients who achieved SVR.